Prasad Raju bought CRSP
March 14, 2024 · Form 4 insider transaction
Prasad Raju bought 10,000 shares of CRISPR Therapeutics AG, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
N/A
Total value
N/A
InsiderPrasad Raju
RoleOfficer
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateMarch 14, 2024
Filing dateMarch 18, 2024
Shares owned after10,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.